Review Article
Volume 11 Issue 5 - 2020
Saga of the Rheumatoid Arthritis Activity Criteria
Yu V Muraviov1* and LA Muraviova2
1V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
2Central Polyclinic Department of MBUZ [Municipal Budgetary Healthcare Institution] Khimki Central Clinical Hospital, Moscow, Khimki, Russia
*Corresponding Author: Yu V Muraviov, V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.
Received: February 17, 2020; Published: April 29, 2020




Abstract

The analysis of ideas about the rheumatoid arthritis activity criteria demonstrated not only the evolution of the its severity assessment, but also the advantages of domestic criteria, facilitating their use in routine clinical practice on the one hand, and the possible reasons making it difficult to use them on the other hand. The foreign colleagues have developed the complex indices that are inferior to the domestic criteria for diagnosing the rheumatoid arthritis activity in the number of objective indicators and ease of determination for a targeted assessment of the inflammatory process activity. In addition, a comparative study of the activity, widely determined by DAS28 and domestic criteria, showed a high level of statistical correlation, which allows us to discuss not only the appropriateness of using the latter in clinical practice, but to recommend it in the clinical studies as well.

Keywords: Rheumatoid Arthritis; Activity Criteria; DAS28

References

  1. Taylor DA. “Table for the Degree of Involvement in Chronic Arthritis”. Canadian Medical Association Journal 36.6 (1937): 608-610.
  2. Cecil R. “Necessity of certain criteria for diagnosis and cure of rheumatoid arthritis”. Annals of Internal Medicine 11 (1937): 637.
  3. Steinbrocker O. “Therapeutic results in rheumatoid arthritis”. Journal of the American Medical Association 131 (1946): 189-193. 
  4. Steinbrocker O., et al. “Therapeutic criteria in rheumatoid arthritis”. Journal of the American Medical Association 140.8 (1949): 659-662.
  5. Astapenko MG and Pihlak EG. “Diseases of the joints”. Izd-vo “Medicine”, Moscow (1966): 380.
  6. Otto V., et al. “Improvement and testing of criteria for the diagnosis of process activity in rheumatoid arthritis”. Issue of Rheumatism 3 (1975): 18-21.
  7. Nasonova VA and Astapenko MG. “Clinical Rheumatology, Manual for Doctors”. Academy of Medical Sciences of the USSR, Moscow: Medicine (1989): 592.
  8. Rheumatic diseases. Guide for doctors. Ed. VA Nasonova, NV Bunchuka. M: Medicine (1997): 520.
  9. Dormidontov EN., et al. “Rheumatoid arthritis”. M: Medicine (1981): 54-61.
  10. Pinals RS., et al. “Preliminary criteria for clinical remission in rheumatoid arthritis”. Arthritis and Rheumatology 24.10 (1981): 1308-1315.
  11. Boers M., et al. “World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials”. Journal of Rheumatology Supplement 41 (1994): 86-89.
  12. van der Heijde DM., et al. “Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score”. Annals of the Rheumatic Diseases 49.11 (1990): 916-920.
  13. Prevoo ML., et al. “Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis”. Arthritis and Rheumatology 38.1 (1995): 44-48.
  14. Fransen J., et al. “Disease Activity Scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity”. Annals of the Rheumatic Diseases 62.1 (2004): 151.
  15. van Gestel AM., et al. “Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria”. Arthritis and Rheumatology 39.1 (1996): 34-40.
  16. Radovits BJ., et al. “Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis”. Annals of the Rheumatic Diseases 67.8 (2008): 1127-1131.
  17. Van der Heijde DM and Jacobs JW. “The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al”. Arthritis and Rheumatology 41.5 (1998): 942-945.
  18. Jurado RL. “Why Shouldn't We Determine the Erythrocyte Sedimentation Rate?” Clinical Infectious Diseases 33.4 (2001): 548-549.
  19. Clinical recommendations. Rheumatology. Under the editorship of EL Nasonov. M: GEOTAR-Media (2005): 46-48
  20. Landewé R., et al. “Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission”. Annals of the Rheumatic Diseases 65.5 (2006): 637-641.
  21. Aletaha D., et al. “Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states”. Arthritis and Rheumatology 52.9 (2005): 2625-2636.
  22. Aletaha D., et al. “Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score”. Arthritis Research and Therapy 7.4 (2005): 796-806.
  23. Gülfe A., et al. “Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents”. BMC Musculoskeletal Disorders 10 (2009): 41.
  24. Bakker MF., et al. “Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility”. Annals of the Rheumatic Diseases 66.3 (2007): iii56-iii60.
  25. Mäkinen H., et al. “Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?” Annals of the Rheumatic Diseases 64.10 (2005): 1410-1413.
  26. Aletaha D and Smolen J. “The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis”. Clinical and Experimental Rheumatology 23.5 (2005): S100-S108.
  27. Hensor EM., et al. “Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced?” Rheumatology (Oxford) 49.8 (2010): 1521-1529.
  28. Wells G., et al. “Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate”. Annals of the Rheumatic Diseases 68.6 (2009): 954-960.
  29. Inoue E., et al. “Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values”. Annals of the Rheumatic Diseases 66.3 (2007): 407-409.
  30. Emery P., et al. “Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis”. Rheumatology International 27.9 (2007): 793-806.
  31. Landewé R. “Predictive markers in rapidly progressing rheumatoid arthritis”. Journal of Rheumatology 80 (2007): 8-15.
  32. Plant MJ., et al. “Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis”. Arthritis and Rheumatology 43.7 (2000): 1473-1477.
  33. Chichasova NV., et al. “Modern approaches to assessing the activity of rheumatoid arthritis”. Ter Archive 5 (2002): 57-60
  34. Emery P and Salmon M. “Early rheumatoid arthritis: time to aim for remission?” Annals of the Rheumatic Diseases 54.12 (1995): 944-947.
  35. van Tuyl LH., et al. “Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference”. Arthritis and Rheumatology 61.5 (2009): 704-710.
  36. Smolen JS and Aletaha D. “What should be our treatment goal in rheumatoid arthritis today?” Clinical and Experimental Rheumatology 24.6 (2006): 7-13.
  37. Trofimova TM., et al. “Clinical examination of patients with rheumatoid arthritis”. Rheumatology 3 (1985): 25-28.
  38. Combe B., et al. “EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)”. Annals of the Rheumatic Diseases 66.1 (2007): 34-45.
  39. Smolen JS., et al. “T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force”. Annals of the Rheumatic Diseases 69.4 (2010): 631-637.
  40. Khanna D., et al. “Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort”. Arthritis and Rheumatology 57.3 (2007): 440-447.
  41. Smolen JS., et al. “Treating rheumatoid arthritis to target: recommendations of an international task force”. Annals of the Rheumatic Diseases 69.4 (2010): 631-637.
  42. van Tuyl LH., et al. “Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review”. Arthritis Care and Research 62.1 (2010): 108-117.
  43. Felson DT., et al. “American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials”. Arthritis and Rheumatology 63.3 (2011): 573-586.
  44. Felson DT., et al. “American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials”. Annals of the Rheumatic Diseases 70.3 (2011): 404-413.
  45. Shahouri SH., et al. “Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria”. Arthritis and Rheumatology 63.11 (2011): 3204-3215.
Citation: Yu V Muraviov and LA Muraviova. “Saga of the Rheumatoid Arthritis Activity Criteria”. EC Orthopaedics 11.5 (2020): 118-126.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.